The protoxin Cry1Ac of Bacillus thuringiensis improves the protection conferred by intranasal immunization with Brucella abortus RB51 in a mouse model

Veterinary Microbiology

Volumn 175, Issue 2-4, 2015, Pages 382-388

  González González, Edith ^a   García Hernández, Ana Lilia ^a   Flores Mejía, Raúl ^b   López Santiago, Rubén ^b   Moreno Fierros, Leticia ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Adjuvants; Brucellosis; Cry1Ac protoxin; Intranasal vaccine; RB51 vaccine

Indexed keywords

BRUCELLA VACCINE; CRY1AC TOXIN; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL PROTEIN; ENDOTOXIN; HEMOLYSIN; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; INSECTICIDAL CRYSTAL PROTEIN, BACILLUS THURINGIENSIS;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BRUCELLA ABORTUS; BRUCELLA ABORTUS RB51; BRUCELLOSIS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG POTENTIATION; FEMALE; IMMUNITY; IMMUNIZATION; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; TRANSFERENCE; ANIMAL; BAGG ALBINO MOUSE; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; SPLEEN; VACCINATION;

ANIMALIA; BACILLUS THURINGIENSIS; BACTERIA (MICROORGANISMS); BRUCELLA MELITENSIS BIOVAR ABORTUS; MUS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; BACTERIAL PROTEINS; BRUCELLA ABORTUS; BRUCELLA VACCINE; BRUCELLOSIS; ENDOTOXINS; HEMOLYSIN PROTEINS; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; SPLEEN; VACCINATION;

EID: 84922745959     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2014.11.021     Document Type: Article

References (24)

1. Akgul O., Ozgocmen S. Infliximab and brucellosis: not the usual suspects, this time. Mod. Rheumatol. 2011, 21:313-315.
2. Baldwin C.L., Goenka R. Host immune response to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection?. Crit. Rev. Immunol. 2006, 26:407-442.
3. Barber D.L., Wherry E.J., Ahmed R. Cutting edge: rapid in vivo killing by memory CD8T cells. J. Immunol. 2003, 171:27-31.
4. de Bagüés M.P.J., Elzer P.H., Jones S.M., Blasco J.M., Enright F.M., Schurig G.G., Winter A.J. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strain of Brucella abortus, Brucella melitensis and Brucella ovis. Infect. Immun. 1994, 62:4990-4996.
5. Fitch T.A., Kahl-McDonagh M.M., Arenas-Gamboa A.M., Rice-Fitch A.C. Brucellosis: the case for live attenuated vaccines. Vaccine 2009, 27:D40-D43.
6. Giambartolomei G.H., Baldi P.C. Immunopathology of Brucella infection. Rev. Sci. Tech. 2013, 32:117-125.
7. Goenka R., Guirnalda P.D., Black S.J., Baldwin C.L. B lymphocytes provide an infection niche for intracellular bacterium Brucella abortus. J. Infect. Dis. 2012, 206:91-98.
8. Grilló M.J., Blasco J.M., Gorvel J.P., Moriyón I., Moreno E. What have we learned from brucellosis in the mouse model?. Vet. Res. 2012, 43:29-64.
9. Ibarra-Moreno S., García-Hernández A.L., Moreno-Fierros L. Coadministration of protoxin Cry1Ac from Bacillus thuringiensis with metacestode extract confers protective immunity to murine cysticercosis. Parasite Immunol. 2014, 36:266-270.
10. Kahl-Mc-Donagh M.M., Arenas-Gamboa A.M., Fitch T.A. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge. Infect. Immun. 2007, 75:4923-4932.
11. Ko J., Splitter G.A. Molecular host-pathogen interactions in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 2003, 16:65-78.
12. Legorreta-Herrera M., Oviedo-Meza R., Moreno-Fierros L. Pretreatment with Cry1Ac protoxin modulates the immune response, and increases the survival of Plasmodium-infected CBA/Ca mice. J. Biomed. Biotechnol. 2010, 2010:198921.
13. Menese M.G., Van de Verg L.L., Bhattacharjee A.K., Garrett J.L., Hart J.A., Lindler L.E., Hatfield T.L., Hoover D.L. Bacteriologic and histologic features in mice after intranasal inoculation of Brucella melitensis. Am. J. Vet. Res. 2001, 62:398-405.
14. Montaraz J.A., Winter A.J. Comparison of living and no living vaccines for Brucella abortus in BALB/c mice. Infect. Immun. 1986, 53:245-251.
15. Moreno-Fierros L., Ruiz-Medina E.J., Esquivel R., López-Revilla R., Piña-Cruz S. Intranasal Cry1Ac protoxin is an effective mucosal and systemic carrier and adjuvant of Streptococcus pneumoniae polysaccharides in mice. Scand. J. Immunol. 2003, 57:45-55.
16. Moreno-Fierros L., García-Hernández A.L., Ilhuicatzi-Alvarado D., Rivera-Santiago L., Torres-Martínez M., Rubio-Infante N., Legorreta-Herrera M. Cry1Ac protoxin from Bacillus thuringiensis promotes macrophage activation by upregulating CD80 and CD86 and by inducing IL-6, MCP-1 and TNF-α cytokines. Int. Immunopharmacol. 2013, 17:1051-1066.
17. Motaharinia Y., Rezaee M.A., Rashidi A., Jalil A., Rezaie M.J., Shapouri R., Hossieni W., Rahmani M.R. Induction of protective immunity against brucellosis in mice by vaccination with a combination of naloxone, alum and heat-killed Brucella melitensis 16 M. J. Microbiol. Immunol. Infect. 2013, 46:253-258.
18. Rojas-Hernández S., Rodríguez-Monroy A.A., López-Revilla A., Reséndiz-Albor A.A., Moreno-Fierros L. Intranasal coadministration of the Cry1Ac protoxin with amoebal lysates increase protection against Naegleria fowleri meningoencephalitis. Infect. Immun. 2004, 72:4368-4375.
19. Scott D.E., Golding H., Huang L.Y., Inman J., Golding B. HIV peptide conjugated to heat-killed bacteria promotes antiviral response in immunodeficient mice. AIDS Res. Hum. Retrovir. 1998, 14:1263-1269.
20. Schurig G.G., Martin-Roop I.I.R., Bagchi T., Boyle S., Buhrman D., Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet. Microbiol. 1991, 28:171-188.
21. Spera J.M., Hermann C.K., Roset M.S., Comerci D.J., Ugalde J.E. A Brucella virulence factor targets macrophages to trigger B-cell proliferation. J. Biol. Chem. 2013, 28:20208-20216.
22. Surendran N., Sriranganathan N., Lawler H., Boyle S.M., Hiltbold E.M., Heid B., Zimmerman K., Witonsky S.G. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice. Vaccine 2011, 29:2749-2755.
23. Yang X., Becker T., Walters N., Pascual D. Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge. Infect. Immun. 2006, 74:3874-3879.
24. Zhan Y., Kelso A., Cheers C. Cytokine production in the murine response to Brucella infection or immunization with antigenic extracts. Immunology 1993, 80:458-464.